Lopinavir is a medicine used to manage viral infections. Stopping the replication of viral particles, this treatment helps reduce the total number of viruses in the body.
When a virus hijacks a cell’s machinery, the body’s immune system can become overwhelmed. Lopinavir belongs to a class of medicines called protease inhibitors, which target a specific step in the viral life-cycle. Its primary therapeutic role is to help keep the amount of virus in the bloodstream low, supporting the immune system in people living with HIV. This active compound is found in the combination product Kaletra, which is approved for use in Singapore.
If you look at the packaging of Kaletra, you’ll see that it pairs Lopinavir with a small amount of ritonavir. Both ingredients are provided together in tablet form, though some markets also offer a liquid formulation for patients who have difficulty swallowing pills. In Singapore, the drug is available as a generic product and under the brand name Kaletra, both meeting the same quality standards set by the Health Sciences Authority.
When clinicians choose Lopinavir-based therapy, they are generally addressing HIV infection. The medication assists with lowering the viral load, which can delay disease progression and reduce the risk of complications. It is often prescribed for adults and adolescents whose viral strain is known to respond well to protease inhibitors. In some cases, the same combination has been investigated for other viral illnesses, but its main approved use remains HIV management.
If the virus tries to multiply, Lopinavir steps in to block an enzyme called protease that the virus needs to cut large protein pieces into functional parts. By hindering this process, the drug prevents new viral particles from becoming fully formed and infectious. The result is a slower spread of the virus inside the body, giving the immune system a better chance to keep up.
Mild nausea, diarrhea, and occasional stomach discomfort are among the most frequently reported experiences. Some people notice a temporary change in taste or a mild headache, which usually improve with continued use.
Rare but important warning signs include severe abdominal pain, persistent vomiting, or signs of liver trouble such as yellowing of the skin or eyes. If any of these occur, medical attention should be sought promptly.
Pregnant individuals should discuss the use of Lopinavir-based medicines with their healthcare team, as pregnancy can affect drug handling in the body. People with known hypersensitivity to Lopinavir or ritonavir, as well as those with severe liver impairment, should avoid this medication.
Alcohol and certain other medicines, especially those that affect liver enzymes, can alter how Lopinavir works. Always check the medication’s packaging or patient information leaflet for specific interaction guidance.
If you keep the tablets in a cool, dry place away from direct sunlight, the product remains stable for its intended shelf life. Treatment duration varies depending on the individual’s response and the specific formulation of Kaletra used. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of Lopinavir and is not medical advice. Medicines that contain this ingredient, such as Kaletra, may differ in formulation, strength, and usage directions. The information herein does not replace professional clinical judgment, and no liability is assumed for how the content is applied. Readers are encouraged to review the labeling of their specific medication and seek guidance from a qualified healthcare professional.
For those who want to explore the source material behind this summary, the following resources are available:
